Overall, while other steps in the EGFR pathway and downstream signals can be regulated by procyanidins [21,39], NOX1 emerges as a central target in ECG and EGCG dimer anti-CRC actions [39]. This evidence concerns the gene NOX1 and colorectal carcinoma.